Clinical trial

Does Sildenafil Protect Against Pulmonary Related Complications Following…

NCT00350441 · NHS Greater Glasgow Yorkhill Division, Other · Unknown status

Key facts

NCT number NCT00350441
Title Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?
Official title A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study of the Pre-Operative Effect of Sildenafil Citrate on Pulmonary Related Complications Following Cardiopulmonary Bypass in Children Undergoing Cardiac Surgical Repair.
Lead sponsor NHS Greater Glasgow Yorkhill Division, Other
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Cardiopulmonary Bypass
Intervention type Drug
Interventions Sildenafil Citrate
Enrollment 12
Start date Jun 1, 2006
First posted Jul 10, 2006
Last update posted Oct 11, 2006
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies